Suchergebnisse - "He, Linrong"

PubPharm (20)

1

Fever, low back pain and skin ulcerations

enthalten in: Annals of the rheumatic diseases | 2024

von He, L. | Ge, Y. | Shu, X.

2

Spontaneous pneumomediastinum in anti-MDA5-positive dermatomyositis : Prevalence, risk factors, and prognosis

enthalten in: Seminars in arthritis and rheumatism | 2024

von Jin, Q. | Lin, S. | Chen, X. | +9

3

High prevalence and mortality of Pneumocystis jirovecii pneumonia in anti-MDA5 antibody-positive dermatomyositis

enthalten in: Rheumatology (Oxford, England) | 2023

von Chen, X. | Shu, X. | He, L. | +4

4

Regioselective Synthesis of Indole-Fused Seven-Membered N-Heterocycles via Photoredox-Catalyzed Intramolecular Cyclization

enthalten in: The Journal of organic chemistry | 2022

von Zhang, Z. | Chen, Y. | He, L. | +2

5

Clinical Heterogeneity of Patients With Antinuclear Matrix Protein 2 Antibody-Positive Myositis : A Retrospective Cohort Study in China

enthalten in: The Journal of rheumatology | 2022

von Li, S. | Sun, C. | Zhang, L. | +8

CommentIn: Int J Rheum Dis. 2023 Sep;26(9):1660-1662. - PMID 37664959

6

Clinical role of bronchoalveolar lavage in dermatomyositis-associated interstitial lung disease

enthalten in: Rheumatology (Oxford, England) | 2021

von He, L. | Ge, Y. | Li, S. | +8

7

The effects of infliximab in treating idiopathic inflammatory myopathies : A review article

enthalten in: Dermatologic therapy | 2021

von Ge, Y. | Li, S. | Chen, F. | +4

8

Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis responds to rituximab therapy

enthalten in: Clinical rheumatology | 2021

von Ge, Y. | Li, S. | Tian, X. | +3

9

Interstitial Lung Disease Is a Major Characteristic of Patients Who Test Positive for Anti-PM/Scl Antibody

enthalten in: Frontiers in medicine | 2021

von Ge, Y. | Shu, X. | He, L. | +3

10

Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis responds to rituximab therapy

enthalten in: Clinical rheumatology | 2021

von Ge, Y. | Li, S. | Tian, X. | +3